Jutta K. Preiksaitis

Jutta K. Preiksaitis

Auto-generated profile, based on publicly available information

Jutta K. Preiksaitis

Department of Medicine University of Alberta Edmonton Alberta Canada

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
UAUpton D. Allen
Upton D. Allen
JPJutta K. Preiksaitis
Jutta K. Preiksaitis
TPthe AST Infectious Diseases Community of Practice
the AST Infectious Diseases Community of Practice

1 April 2017 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
YTYupin Tong
Yupin Tong
XPXiaoli L. Pang
Xiaoli L. Pang
CMCurtis Mabilangan
Curtis Mabilangan
JPJutta K. Preiksaitis
Jutta K. Preiksaitis
Whether cytomegalovirus (CMV) DNA exists in plasma as virion-associated or free DNA is uncertain. An assay combining DNase I digestion and CMV quantitative polymerase chain reaction (DNase-CMV-qPCR) was developed to differentiate free naked DNA from virion DNA. One hundred three frozen and 10 fresh CMV DNA–positive plasma samples from solid-organ transplant recipients (SOTRs) were tested. Three sets of paired qPCR (P-qPCR) assays with amplicons of variable length were used to study CMV DNA fragmentation in 20 SOTR plasma samples, viral stocks (Towne, Merlin, AD169) and the first World Health Organization (WHO) international standard (IS) for CMV DNA. In all plasma samples, 98.8%–100% of CMV DNA was free DNA; this was the only form in 93 of 103 (90.3%) frozen and all 10 fresh samples tested using DNase-CMV-qPCR. Low levels of virion CMV DNA were found in 10 of 103 (9.7%) samples with higher total DNA load. Cytomegalovirus DNA results were highly reproducible for 3 CMV virus stocks and WHO IS (P > .80), tested by three sets of paired q-PCR. However, for the 20 SOTR plasma samples, the smaller amplicon assay result was 2.6-fold, 3.4-fold, and 6.5-fold higher than the longer amplicion result (P < .001). Cytomegalovirus DNA in SOTR plasma is almost exclusively free DNA, highly fragmented, and not virion associated.

5 May 2021 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
SHStan Houston
Stan Houston
SBSara Belga
Sara Belga
KBKlaus Buttenschoen
Klaus Buttenschoen
RCRyan D. Cooper
Ryan D. Cooper
SGSafwat Girgis
Safwat Girgis
KKKinga Kowalewska-Grochowska
Kinga Kowalewska-Grochowska
Human alveolar echinococcosis (AE) is a zoonotic cestode infection which is usually fatal in the absence of treatment. Treatment involves major surgery or indefinite antiparasitic therapy. The incidence is rising in Europe and Asia, with an increased risk observed in immunocompromised individuals. Previously, AE acquisition in North America was extremely rare, except for one remote Alaskan Island. Recent studies have demonstrated a new European-like strain of Echinococcus multilocularis (Em) in wildlife and in human AE in western Canada. We report the experience of all AE patients diagnosed in Alberta. Each was diagnosed by histopathology, serology, and PCR-confirmed by a reference laboratory. Seventeen cases of human AE, aged 19–78 years, nine females, were diagnosed between 2013 and 2020: all definitely or probably acquired in Alberta. Six lived in urban areas, and 14 had kept dogs. In eight, the lesions were found incidentally on abdominal imaging performed for other indications. Six were immunocompromised to varying degrees. Six were first diagnosed at surgery. All have been recommended benzimidazole therapy. One died of surgical complications. Clinicians should be aware of this diagnostic possibility in patients presenting with focal nonmalignant hepatic mass lesions. Greater urbanization of coyotes, the predominant definitive host of Em in Alberta, and growing numbers of immune suppressed individuals in the human population may lead to increasing recognition of AE in North America.

9 October 2018 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
RSRyan J. Stubbins
Ryan J. Stubbins
NLNassiba Alami Laroussi
Nassiba Alami Laroussi
APAnthea C. Peters
Anthea C. Peters
SUSimon Urschel
Simon Urschel
FDFrank Dicke
Frank Dicke
JPJutta K. Preiksaitis
Jutta K. Preiksaitis

11 November 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
BBBruno Fernando Buzo
Bruno Fernando Buzo
JPJutta K. Preiksaitis
Jutta K. Preiksaitis
KHKieran Halloran
Kieran Halloran
JNJayan Nagendran
Jayan Nagendran
DTDerek R. Townsend
Derek R. Townsend
WSWendy I. Sligl
Wendy I. Sligl
Hyperammonemia syndrome (HS) is a rare complication with high mortality described after lung transplantation. Its pathophysiology is still unclear, but previous studies, including murine models, have linked the identification of Mycoplasmataceae in airway specimens with HS occurrence. This study explores the association between Mycoplasmataceae polymerase chain reaction (PCR) positivity, ammonia levels, HS and mortality post‐lung transplant. Adults who underwent lung transplantation between July 2017 and August 2019 had prospective surveillance testing for Mycoplasma and Ureaplasma using PCR on post‐operative bronchoscopy samples. 159 patients underwent lung transplantation during the study period. Mean age was 54 (±13) years; baseline diseases were predominantly pulmonary fibrosis (37.7%) and chronic obstructive pulmonary disease (35.8%). Mycoplasma and/or Ureaplasma airway positivity was found in 42 (26.4%) of tested patients, represented mostly by M. salivarium (26/43; 60.4%), U. parvum (7/43; 16.2%) and U. urealyticum (5/43; 11.6%). Median peak ammonia levels were higher in those with Ureaplasma colonization compared to uncolonized patients (p=0.04) however only three patients developed HS. Recipient airway Ureaplasma‐positivity was independently associated with younger (aOR 0.94, 95%CI 0.88‐0.99, p=0.04) and female donors (aOR 4.29; 95%CI 1.01‐18.2, p=0.05).

1 July 2016 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MHMaria Hasing
Maria Hasing
BHBart Hazes
Bart Hazes
BLBonita Lee
Bonita Lee
JPJutta K. Preiksaitis
Jutta K. Preiksaitis
XPXiaoli L. Pang
Xiaoli L. Pang
Immunocompromised individuals with chronic norovirus (NoV) infection and elderly patients are hypothesized to be reservoirs where NoV might accumulate mutations and evolve into pandemic strains. Next generation sequencing (NGS) methods can monitor the intra-host diversity of NoV and its evolution but low abundance of viral RNA results in sub-optimal efficiency. In this study, we: 1) established a next generation sequencing-based method for NoV using bacterial rRNA depletion as a viral RNA enrichment strategy, and 2) measured the intra-host genetic diversity of NoV in specimens of patients with acute NoV infection (n = 4) and in longitudinal specimens of an immunocompromised patient with chronic NoV infection (n = 2). A single Illumina MiSeq dataset resulted in near full-length genome sequences for 5 out of 6 multiplexed samples. Experimental depletion of bacterial rRNA in stool RNA provided up to 1.9 % of NoV reads. The intra-host viral population in patients with acute NoV infection was homogenous and no single nucleotide variants (SNVs) were detected. In contrast, the NoV population from the immunocompromised patient was highly diverse and accumulated SNVs over time (51 SNVs in the first sample and 122 SNVs in the second sample collected 4 months later). The percentages of SNVs causing non-synonymous mutations were 27.5 % and 20.5 % for the first and second samples, respectively. The majority of non-synonymous mutations occurred, in increasing order of frequency, in p22, the major capsid (VP1) and minor capsid (VP2) genes. The results provide data useful for the selection and improvement of NoV RNA enrichment strategies for NGS. Whole genome analysis using next generation sequencing confirmed that the within-host population of NoV in an immunocompromised individual with chronic NoV infection was more diverse compared to that in individuals with acute infection. We also observed an accumulation of non-synonymous mutations at the minor capsid gene that has not been reported in previous studies and might have a role in NoV adaptation.